|
HK1004520A1
(en)
|
1992-05-13 |
1998-11-27 |
Novartis Ag |
Ophthalmic compositions containing a cyclosporin
|
|
NZ247516A
(en)
|
1993-04-28 |
1995-02-24 |
Bernard Charles Sherman |
Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
|
|
US5484597A
(en)
*
|
1993-07-30 |
1996-01-16 |
Chesebrough-Pond's Usa Co. |
Clear hydroalcholic cosmetic microemulsions
|
|
NZ280689A
(en)
|
1995-12-15 |
1997-08-22 |
Bernard Charles Sherma Sherman |
Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
|
|
MX9701946A
(es)
|
1997-03-14 |
1998-04-30 |
Arturo Jimenez Bayardo |
Solucion oftalmica transportadora.
|
|
US7678836B2
(en)
|
1999-11-04 |
2010-03-16 |
Fxs Ventures, Llc |
Method for rendering a contact lens wettable
|
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
|
EP1296923B3
(en)
|
2000-02-16 |
2012-04-11 |
The Brigham And Women's Hospital, Inc. |
Aspirin-triggered lipid mediators
|
|
US20030176356A1
(en)
|
2001-04-24 |
2003-09-18 |
University Of North Texas Health Science Center |
Endothelin antagonists and endothelin-converting enzyme inhibitors for the treatment of glaucoma
|
|
PL206018B1
(pl)
|
2001-10-19 |
2010-06-30 |
Isotechnika Inc |
Preparat farmaceutyczny, sposób jego wytwarzania, mikroemulsja i zastosowanie tego preparatu farmaceutycznego
|
|
US7030159B2
(en)
|
2001-12-18 |
2006-04-18 |
The Brigham And Women's Hospital, Inc. |
Approach to anti-microbial host defense with molecular shields with EPA and DHA analogs
|
|
US6949664B2
(en)
|
2002-04-01 |
2005-09-27 |
University Of Southern California |
Trihydroxy polyunsaturated eicosanoids
|
|
US7582785B2
(en)
|
2002-04-01 |
2009-09-01 |
University Of Southern California |
Trihydroxy polyunsaturated eicosanoid derivatives
|
|
DE60330154D1
(de)
|
2002-08-12 |
2009-12-31 |
Brigham & Womens Hospital |
Resolvine: biotemplate zur durchführung therapeutischer anwendungen
|
|
US7759395B2
(en)
|
2002-08-12 |
2010-07-20 |
The Brigham And Women's Hospital, Inc. |
Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
|
|
US20040213782A1
(en)
|
2003-02-03 |
2004-10-28 |
Pharmacia Corporation |
Compositions of an aquaporin modulating agent and an aqueous humor modulating agent for the treatment of elevated intraocular pressure
|
|
JP2004238346A
(ja)
|
2003-02-07 |
2004-08-26 |
Shiono Chemical Co Ltd |
トラニラストの安定な水溶液製剤
|
|
WO2004078143A2
(en)
|
2003-03-05 |
2004-09-16 |
The Brigham And Women's Hospital Inc. |
Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs
|
|
WO2004096261A1
(es)
|
2003-05-02 |
2004-11-11 |
Arturo Jimenez Bayardo |
Metodo para preparar una solucion acuosa de ciclosporina-a y solucion acuosa resultante
|
|
US7087237B2
(en)
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
US20050238589A1
(en)
|
2004-04-14 |
2005-10-27 |
Van Dyke Thomas E |
Methods and compositions for preventing or treating periodontal diseases
|
|
DE602004017477D1
(de)
|
2004-11-09 |
2008-12-11 |
Novagali Pharma Sa |
Öl-in-Wasser-Emulsion mit niedriger Konzentration des kationischen Mittels und positivem Zetapotential
|
|
JP2008520739A
(ja)
|
2004-11-19 |
2008-06-19 |
マーテック・バイオサイエンシーズ・コーポレーション |
長鎖多価不飽和脂肪酸由来のオキシリピンならびにその作製および使用方法
|
|
RU2007149249A
(ru)
|
2005-06-09 |
2009-07-20 |
Сантен Фармасьютикал Ко., Лтд (Jp) |
Глазные капли, содержащие рофлумиласт
|
|
CA2609251A1
(en)
|
2005-06-16 |
2006-12-28 |
Myriad Genetics, Inc. |
Pharmaceutical compositions and use thereof
|
|
US20070015691A1
(en)
|
2005-07-13 |
2007-01-18 |
Allergan, Inc. |
Cyclosporin compositions
|
|
WO2007011880A2
(en)
|
2005-07-18 |
2007-01-25 |
Minu, L.L.C. |
Enhanced ocular neuroprotection/neurostimulation
|
|
WO2007090162A2
(en)
|
2006-01-31 |
2007-08-09 |
Martek Biosciences Corporation |
OXYLIPINS FROM STEARIDONIC ACID AND γ-LINOLENIC ACID AND METHODS OF MAKING AND USING THE SAME
|
|
US10137083B2
(en)
|
2006-03-07 |
2018-11-27 |
SGN Nanopharma Inc |
Ophthalmic preparations
|
|
JPWO2007126110A1
(ja)
|
2006-04-24 |
2009-09-17 |
ナノキャリア株式会社 |
低分子薬物内包ポリマーミセルの製造方法
|
|
WO2007136134A1
(ja)
|
2006-05-23 |
2007-11-29 |
Nanocarrier Co., Ltd. |
疎水性薬物内包ポリマーミセルの製造方法
|
|
KR101363498B1
(ko)
|
2006-07-18 |
2014-02-14 |
나노캬리아 가부시키가이샤 |
생리활성 폴리펩티드 또는 단백질 내포 고분자 폴리머 미셀및 그 제조방법
|
|
EP2120920A4
(en)
|
2007-02-20 |
2011-06-15 |
Martek Biosciences Corp |
OXYLIPINES OF LONG-CHAIN MULTIPLE-UNSATURATED FATTY ACIDS AND METHOD FOR THEIR PREPARATION AND USE
|
|
US20100310462A1
(en)
|
2007-04-18 |
2010-12-09 |
Biochromix Ab |
Binding of pathological forms of proteins using conjugated polyelectrolytes
|
|
US8512687B2
(en)
|
2007-07-09 |
2013-08-20 |
Novagali Pharma Sa |
Oil in water emulsion comprising NSAIDs and quaternary ammonium halides
|
|
US9456980B2
(en)
|
2007-08-29 |
2016-10-04 |
Wakamoto Pharmaceutical Co., Ltd. |
Latanoprost-containing aqueous pharmaceutical composition
|
|
MX2007011165A
(es)
|
2007-09-12 |
2009-03-11 |
Arturo Jimenez Bayardo |
Composición farmacéutica estable de timolol, dorzolamida y brimonidina.
|
|
JP5668476B2
(ja)
|
2007-10-08 |
2015-02-12 |
オーリニア・ファーマシューティカルズ・インコーポレイテッドＡｕｒｉｎｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． |
カルシニューリン阻害剤またはｍＴＯＲ阻害剤を含む眼科用組成物
|
|
CN101990437A
(zh)
|
2008-01-04 |
2011-03-23 |
阿尔康药品有限公司 |
稳定的环孢菌素水性组合物
|
|
TWI544927B
(zh)
|
2008-03-17 |
2016-08-11 |
愛爾康研究有限公司 |
具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
|
|
KR20110010788A
(ko)
|
2008-05-28 |
2011-02-07 |
알콘 리서치, 리미티드 |
자기보존 에멀젼
|
|
EP2127638A1
(en)
|
2008-05-30 |
2009-12-02 |
Santen Pharmaceutical Co., Ltd |
Method and composition for treating ocular hypertension and glaucoma
|
|
JP2012528857A
(ja)
|
2009-06-02 |
2012-11-15 |
ウー，ニエン |
純粋ｐｅｇ−脂質コンジュゲート
|
|
WO2010144194A1
(en)
|
2009-06-09 |
2010-12-16 |
Lux Biosciences, Inc. |
Topical drug delivery systems for ophthalmic use
|
|
CA2773597A1
(en)
|
2009-09-17 |
2011-03-24 |
Senju Pharmaceutical Co., Ltd. |
Latanoprost-containing aqueous eye drops and method for inhibiting adsorption of latanoprost to resin
|
|
US8637569B2
(en)
|
2009-10-22 |
2014-01-28 |
Api Genesis, Llc |
Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
|
|
US9011861B2
(en)
|
2010-02-25 |
2015-04-21 |
Schepens Eye Research Institute |
Therapeutic compositions for the treatment of dry eye disease
|
|
MX2012012941A
(es)
|
2010-05-07 |
2013-07-29 |
Sun Pharma Advanced Res Co Ltd |
Nuevas composiciones oftalmicas.
|
|
US20130065888A1
(en)
|
2011-08-15 |
2013-03-14 |
Biserka Cetina-Cizmek |
Ophthalmic formulations and processes for their preparation
|
|
US9278132B2
(en)
|
2012-02-13 |
2016-03-08 |
Bausch & Lomb Incorporated |
Ophthalmic pharmaceutical compositions and methods of making and using same
|
|
KR101211902B1
(ko)
|
2012-04-30 |
2012-12-13 |
주식회사 휴온스 |
사이클로스포린 함유 무자극성 나노에멀젼 안약 조성물
|
|
WO2013167865A1
(en)
|
2012-05-11 |
2013-11-14 |
Cipla Limited |
Pharmaceutical composition
|
|
SI2887923T1
(sl)
|
2012-08-24 |
2023-09-29 |
Sun Pharmaceutical Industries Limited |
Oftalmična formulacija polioksilnega lipida ali polioksilne maščobne kisline in zdravljenje očesnih stanj
|
|
US10946076B2
(en)
|
2013-02-13 |
2021-03-16 |
The Research Foundation For The State University Of New York |
Glaucoma treatment
|
|
WO2015179527A1
(en)
|
2014-05-23 |
2015-11-26 |
Ocular Technologies Sarl |
Topical formulations and uses thereof
|
|
US20150352176A1
(en)
|
2014-06-06 |
2015-12-10 |
Newport Research, Inc. |
Oil-free and fat-free aqueous suspensions of cyclosporin
|
|
US9421199B2
(en)
|
2014-06-24 |
2016-08-23 |
Sydnexis, Inc. |
Ophthalmic composition
|
|
US20180133217A1
(en)
|
2015-05-04 |
2018-05-17 |
Ocular Technologies Sarl |
Topical formulations and uses thereof
|
|
FI3373976T3
(fi)
|
2015-11-10 |
2024-03-25 |
Sun Pharmaceutical Ind Ltd |
Topikaalisia formulaatioita ja niiden käyttöjä
|
|
WO2017083410A1
(en)
|
2015-11-12 |
2017-05-18 |
Ocular Technologies Sarl |
Topical formulations and uses thereof
|
|
WO2017151657A1
(en)
|
2016-02-29 |
2017-09-08 |
Ocular Technologies Sarl |
Topical cyclosporine-containing formulations and uses thereof
|
|
WO2017152129A2
(en)
|
2016-03-03 |
2017-09-08 |
Ocular Technologies Sarl |
Treatment of glaucoma and/or retinal diseases and formulations useful therefore
|